4.7 Article

Quinazolinone-based benzenesulfonamides with low toxicity and high affinity as monoamine oxidase-A inhibitors: Synthesis, biological evaluation and induced-fit docking studies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Neurosciences

The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson's Disease-An Update

Zhi Xin Chew et al.

Summary: Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by reduced dopamine levels. Inhibitors of monoamine oxidase B (MAO-B) are used to alleviate symptoms by preserving functional levels of dopamine. The first MAO-B inhibitor used therapeutically was selegiline, followed by rasagiline, which has superior efficacy. Safinamide, a reversible MAO-B inhibitor, was recently approved as an add-on therapy for mid- or late-stage PD. MAO-B inhibitors may have potential neuroprotective and disease modifying effects, but further investigation is needed.

CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2023)

Article Biochemistry & Molecular Biology

Benzenesulfonamide derivatives as potent acetylcholinesterase, α-glycosidase, and glutathione S-transferase inhibitors: biological evaluation and molecular docking studies

Parham Taslimi et al.

Summary: Sulfonamide derivatives have a wide range of biological activities and potential as medical molecules in drug development. Studies have shown that these compounds have an impact on various enzymes. The synthesized derivatives demonstrate inhibitory effects on AChE, GST, and α-GLY enzymes, with stronger inhibition observed at lower concentrations through the addition of functional electronegative groups.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)

Article Biochemistry & Molecular Biology

Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides

Cem Yamali et al.

Summary: A series of novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides were synthesized and evaluated as inhibitors of carbonic anhydrase isoforms. Some compounds showed selective inhibition towards cancer-related isoforms and moderate cytotoxicity against various cancer cell lines, indicating their potential as anticancer drug candidates.

BIOORGANIC CHEMISTRY (2021)

Article Chemistry, Medicinal

Comprehensive study on potent and selective carbonic anhydrase inhibitors: Synthesis, bioactivities and molecular modelling studies of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl) benzenesulfonamides

Cem Yamali et al.

Summary: This research reported the rational design, synthesis, carbonic anhydrases (CAs) inhibitory effects, and cytotoxicities of a series of 4-(3-(2-arylidenehydrazine-1-carbonyl)-5-(thiophen-2-yl)-1H-pyrazole-1-yl)benzenesulfonamides. The selective inhibitory effects of compound 18 on cancer-associated hCA IX and compound 17 on hCA XI were highlighted. Furthermore, some compounds showed comparable tumor-specificity to doxorubicin towards HSC-2 cancer cell line, with potential correlation to certain chemical descriptors.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Chemistry, Medicinal

Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities

Nihal Gok et al.

Summary: A series of novel dopamine analogs were synthesized incorporating urea and sulfonamide functional groups, exhibiting anticholinergic and antioxidant effects. Compound 13 showed inhibition for both acetylcholinesterase and butyrylcholinesterase, while compounds 16 and 18 demonstrated higher reducing power and better radical scavenging activity.

ARCHIV DER PHARMAZIE (2021)

Article Biochemistry & Molecular Biology

Synthesis of new hydrazone derivatives and evaluation of their monoamine oxidase inhibitory activity

Fatih Tok et al.

Summary: A novel series of hydrazone derivatives were synthesized and evaluated for their inhibitory activity against MAO enzymes. Some compounds showed significant inhibitory activity against MAO-A. The most effective compound, 4i, was studied using enzyme kinetics and docking studies to elucidate its inhibition mechanism, showing promising pharmacokinetic profiles according to ADME predictions.

BIOORGANIC CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Novel imidazo[2,1-b]thiazole-based anticancer agents as potential focal adhesion kinase inhibitors: Synthesis, in silico and in vitro evaluation

Faika Basoglu et al.

Summary: This study focused on synthesizing imidazo[2,1-b]thiazole derivatives, characterizing them, and investigating their cytotoxic and apoptotic effects on glioma C6 cancer cell line, as well as their anticancer activities against focal adhesion kinase. Results showed that compounds with specific structures exhibited higher anticancer activities and FAK inhibitory activities, with molecular docking studies revealing their binding modes and critical interactions with amino acid residues in the active site, providing insights into developing new inhibitors against FAK.

CHEMICAL BIOLOGY & DRUG DESIGN (2021)

Article Chemistry, Physical

OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space

Chao Lu et al.

Summary: The development and validation of the OPLS4 force field, which builds upon previous work with OPLS3e, improved model accuracy on challenging regimes of drug-like chemical space. A novel parametrization strategy for charged species was introduced, leading to improved accuracy on benchmarks assessing small-molecule solvation and protein-ligand binding.

JOURNAL OF CHEMICAL THEORY AND COMPUTATION (2021)

Review Biochemistry & Molecular Biology

Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors

Tapan Behl et al.

Summary: Despite being less utilized in depression treatment compared to other antidepressants, monoamine oxidase inhibitors (MAOIs) have shown potential in neuroprotection and treatment of neurological and psychiatric conditions. Research on MAOIs, particularly on their neuroprotective activities, has been progressing, indicating a possible role in conditions like Alzheimer's disease. The therapeutic potential of MAOIs, especially in neurodegenerative diseases, suggests a promising future for these drugs with a better understanding of their physiology.

MOLECULES (2021)

Review Chemistry, Multidisciplinary

Current Progress in Quinazoline Derivatives as Acetylcholinesterase and Monoamine Oxidase Inhibitors

Nisha Abdul Rehuman et al.

Summary: This review focuses on recent advances in quinazoline derivatives as inhibitors of AChE and MAO, highlighting their molecular determinants and structure-activity relationships on AChE and MAO inhibitory potencies.

CHEMISTRYSELECT (2021)

Article Chemistry, Multidisciplinary

Synthesis and biological evaluation of new pyrazolebenzene-sulphonamides as potential anticancer agents and hCA I and II inhibitors

Mehtap Tugrak et al.

Summary: Cancer is characterized by uncontrolled cell growth, and developing new drug candidate compounds is necessary due to limitations and side effects of existing drugs. In this study, new pyrazole-sulphonamide hybrid compounds were designed and synthesized, with compounds 4i and 4g showing the highest cytotoxicity values. These compounds have the potential to be lead compounds for further research.

TURKISH JOURNAL OF CHEMISTRY (2021)

Article Plant Sciences

Design of microemulsion formulations loaded Scutellaria salviifolia Benth, Sideritis libanotica Labill. subsp. linearis (Bentham) Bornm, and Ziziphora clinopodioides Lam. extracts from Turkey and in vitro evaluation of their biological activities

Umay Merve Guven et al.

Summary: In this study, microemulsion systems were developed with extracts of Sideritis libanotica, Scutellaria salviifolia, and Ziziphora clinopodioides. The Sideritis libanotica extract exhibited strong antibacterial activity against Staphylococcus aureus and had a higher antioxidant capacity compared to other extracts. The microemulsion formulations did not show superior antimicrobial activity but had higher antioxidant capacity than the extracts.

TURKISH JOURNAL OF BOTANY (2021)

Article Biochemistry & Molecular Biology

Sulphonamides incorporating 1,3,5-triazine structural motifs show antioxidant, acetylcholinesterase, butyrylcholinesterase, and tyrosinase inhibitory profile

Nabih Lolak et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Novel 1,3,4-thiadiazole compounds as potential MAO-A inhibitors - design, synthesis, biological evaluation and molecular modelling

Begum Nurpelin Saglik et al.

RSC MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Synthesis,in vitroenzyme activity and molecular docking studies of new benzylamine-sulfonamide derivatives as selective MAO-B inhibitors

Begum Nurpelin Saglik et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

The monoamine oxidase inhibition properties of C6-mono- and N3/C6-disubstituted derivatives of 4(3H)-quinazolinone

Malikotsi A. Qhobosheane et al.

BIOORGANIC CHEMISTRY (2019)

Article Chemistry, Medicinal

1,3,4-Oxadiazol-2-ylbenzenesulfonamides as privileged structures for the inhibition of monoamine oxidase B

Anton Shetnev et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)

Article Biochemistry & Molecular Biology

New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors

Halise Inci Gul et al.

BIOORGANIC CHEMISTRY (2018)

Review Chemistry, Medicinal

Sulfonamide inhibitors: a patent review 2013-present

Ilhami Gulcin et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2018)

Article Biochemistry & Molecular Biology

Synthesis, pharmacology and molecular docking on multifunctional tacrine-ferulic acid hybrids as cholinesterase inhibitors against Alzheimer's disease

Jie Zhu et al.

JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)

Review Clinical Neurology

90years of monoamine oxidase: some progress and some confusion

Keith F. Tipton

JOURNAL OF NEURAL TRANSMISSION (2018)

Article Biochemistry & Molecular Biology

Synthesis and evaluation of 2-substituted 4(3H)-quinazolinone thioether derivatives as monoamine oxidase inhibitors

Malikotsi A. Qhobosheane et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

MAO enzymes inhibitory activity of new benzimidazole derivatives including hydrazone and propargyl side chains

Ozgur Devrim Can et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)

Article Biochemistry & Molecular Biology

Monoamine oxidase inhibitory activity of methoxy-substituted chalcones

Bijo Mathew et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2017)

Review Neurosciences

The SH-SY5Y cell line in Parkinson's disease research: a systematic review

Helena Xicoy et al.

MOLECULAR NEURODEGENERATION (2017)

Article Chemistry, Medicinal

In-Vitro Anticancer Evaluation and Docking Study of Novel Benzo[g] Quinazoline-sulfonamide Derivatives

Mostafa M. Ghorab et al.

MEDICINAL CHEMISTRY (2016)

Article Multidisciplinary Sciences

Antidepressant-like Effects of LPM580153, A Novel Potent Triple Reuptake Inhibitor

Fangxi Zhang et al.

SCIENTIFIC REPORTS (2016)

Article Biochemistry & Molecular Biology

Synthesis and evaluation of quinazoline amino acid derivatives as mono amine oxidase (MAO) inhibitors

Sherine Nabil Khattab et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2015)

Review Chemistry, Medicinal

Quinazoline derivatives as anticancer drugs: a patent review (2011-present)

Severine Ravez et al.

EXPERT OPINION ON THERAPEUTIC PATENTS (2015)

Article Biochemistry & Molecular Biology

Design, synthesis and evaluation of novel quinazoline-2,4-dione derivatives as chitin synthase inhibitors and antifungal agents

Qinggang Ji et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2014)

Article Chemistry, Medicinal

Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents

Mohd Amir et al.

ARCHIVES OF PHARMACAL RESEARCH (2013)

Article Biochemistry & Molecular Biology

Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments

G. Madhavi Sastry et al.

JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)

Article Medicine, Research & Experimental

The interactions of caffeine with monoamine oxidase

Anel Petzer et al.

LIFE SCIENCES (2013)

Article Psychiatry

Dietary Restrictions and Drug Interactions With Monoamine Oxidase Inhibitors

David A. Flockhart

JOURNAL OF CLINICAL PSYCHIATRY (2012)

Review Food Science & Technology

Genesis and development of DPPH method of antioxidant assay

Sagar B. Kedare et al.

JOURNAL OF FOOD SCIENCE AND TECHNOLOGY-MYSORE (2011)

Review Pharmacology & Pharmacy

Monoamine Oxidase Inhibitors as Neuroprotective Agents in Age-Dependent Neurodegenerative Disorders

Makoto Naoi et al.

CURRENT PHARMACEUTICAL DESIGN (2010)

Article Chemistry, Medicinal

Exploring QSAR on 4-Cyclohexylmethoxypyrimidines as Antitumor Agents for Their Inhibitory Activity of CDK2

A. Ece et al.

LETTERS IN DRUG DESIGN & DISCOVERY (2010)

Article Chemistry, Medicinal

Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes

Richard A. Friesner et al.

JOURNAL OF MEDICINAL CHEMISTRY (2006)